SCIE期刊CURRENT CANCER DRUG TARGETS 2024/2025影响因子:2.326 (CURR CANCER DRUG TAR) (1568-0096). (ONCOLOGY)(肿瘤学)Science Citati

显示全部楼层 · 发表于 2025-3-23 13:18:15

Submitted on: 02 July 2007. Revised on: 25 October 2007. Accepted on: 09 December 2007. ___________________CURRENT CANCER DRUG TARGETS---BENTHAM SCIENCE PUBL LTD

显示全部楼层 · 发表于 2025-3-23 17:42:46

显示全部楼层 · 发表于 2025-3-23 19:04:05

显示全部楼层 · 发表于 2025-3-23 23:34:27

Submitted on: 28 December 2014. Revised on: 16 February 2015. Accepted on: 08 April 2015. ___________________CURRENT CANCER DRUG TARGETS---BENTHAM SCIENCE PUBL LTD

显示全部楼层 · 发表于 2025-3-24 03:09:40

Submitted on: 09 August 2017. Revised on: 04 December 2017. Accepted on: 16 January 2018. ___________________CURRENT CANCER DRUG TARGETS---BENTHAM SCIENCE PUBL LTD

显示全部楼层 · 发表于 2025-3-24 09:31:55

显示全部楼层 · 发表于 2025-3-24 11:04:16

Submitted on: 13 October 2022. Revised on: 28 January 2023. Accepted on: 14 February 2023. ___________________CURRENT CANCER DRUG TARGETS---BENTHAM SCIENCE PUBL LTD

显示全部楼层 · 发表于 2025-3-24 18:30:03

显示全部楼层 · 发表于 2025-3-24 21:55:43

显示全部楼层 · 发表于 2025-3-25 02:31:20

Submitted on: 28 August 2007. Revised on: 25 October 2007. Accepted on: 22 December 2007. ___________________CURRENT CANCER DRUG TARGETS---BENTHAM SCIENCE PUBL LTD

		自动登录	找回密码
密码			To register

关于派博传思			派博传思旗下网站			友情链接
派博传思介绍	公司地理位置	论文服务流程	影响因子官网	SITEMAP	大讲堂	北京大学	Oxford Uni.	Harvard Uni.
发展历史沿革	期刊点评	投稿经验总结	SCIENCEGARD	IMPACTFACTOR	派博系数	清华大学	Yale Uni.	Stanford Uni.
\|Archiver\|手机版\|小黑屋\| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-4-29 18:14
Copyright © 2001-2015 派博传思京公网安备110108008328 版权所有 All rights reserved